The anaphase-promoting complex (APC), or cyclosome, is an E3 ubiquitin-protein ligase that collaborates with E2 ubiquitin-conjugating enzymes to assemble polyubiquitin chains on proteins important for cell-cycle progression. It remains unclear how the APC-or many other E3s-promotes the multiple distinct reactions necessary for chain assembly. We addressed this problem by analyzing APC interactions with different E2s. We screened all budding yeast E2s as APC coenzymes in vitro and found that two, Ubc4 and Ubc1, are the key E2 partners for the APC. These proteins display strikingly different but complementary enzymatic behaviors: Ubc4 supports the rapid monoubiquitination of multiple lysines on APC targets, while Ubc1 catalyzes K48-linked polyubiquitin chain assembly on preattached ubiquitins. Mitotic APC function is lost in yeast strains lacking both Ubc1 and Ubc4. E2-25K, a human homolog of Ubc1, also promotes APC-dependent chain extension on preattached ubiquitins. We propose that sequential E2 proteins catalyze K48-linked polyubiquitination and thus proteasomal destruction of APC targets.
INTRODUCTION
Protein ubiquitination is a critical regulatory modification, particularly in the control of protein degradation, whereby the addition of multiple ubiquitins to a protein triggers recognition and destruction by the proteasome (Kerscher et al., 2006; Pickart and Eddins, 2004) . This process is catalyzed by an enzymatic cascade involving a ubiquitinactivating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a ubiquitin-protein ligase (E3). E1 employs ATP hydrolysis to catalyze formation of a thioester bond between the C terminus of ubiquitin and an active-site cysteine on E1. The E1-ubiquitin conjugate binds to an E2, resulting in transfer of the ubiquitin C terminus from E1 to a cysteine in the E2. An E3 then promotes transfer of the ubiquitin from the E2-ubiquitin conjugate to a lysine side chain on the target protein. Repeated cycles of this reaction can lead to the attachment of ubiquitins to several lysines on the target and to specific lysines on ubiquitin itself, resulting in polyubiquitin chains.
E3s contain specific binding sites for two substrates: an E2-ubiquitin conjugate and a protein target. In the case of the large RING-domain family of E3s, the 3-amino group on a lysine side chain in the target protein attacks the E2-ubiquitin thioester linkage, resulting in the formation of an isopeptide bond between the C terminus of ubiquitin and the target lysine. Catalysis depends on residues provided by the E2 (Passmore and Barford, 2004; Pickart and Eddins, 2004; Wu et al., 2003) . RING-domain ligases facilitate the reaction by bringing the two substrates in close proximity and possibly by activating the catalytic function of the E2 (Ozkan et al., 2005) .
Polyubiquitin chain formation results from a linkage between the C terminus of one ubiquitin and a lysine side chain in another (Hochstrasser, 2006; Pickart and Fushman, 2004) . Ubiquitin contains several lysines that can be used as ubiquitination sites (Peng et al., 2003) , but most chains are linked through lysine 48 (K48) or lysine 63 (K63). A K48-linked chain of four or more ubiquitins provides an important recognition signal for destruction in the proteasome (Thrower et al., 2000) . In most cases, polyubiquitin chain assembly is thought to occur by the sequential addition of ubiquitin to a lysine on a ubiquitin already attached to the target (Hochstrasser, 2006) .
Polyubiquitin chain assembly by sequential addition involves two reactions with different lysine specificities. The monoubiquitination reaction-direct attachment of ubiquitin to the protein target-often occurs at multiple lysines in a somewhat random pattern that does not seem to depend on the amino acid sequence context Petroski and Deshaies, 2003) . In contrast, the polyubiquitination reaction typically requires modification of a single specific lysine, such as K48, in ubiquitin. Many E3s are capable of promoting both of these reactions-raising the intriguing question of how a single E3 can carry out two reactions of such distinct specificity. The RING-domain ligase SCF solves this problem by collaborating with a single E2, Cdc34, that catalyzes both the slow attachment of ubiquitin to a lysine in the substrate as well as the rapid extension of a K48-linked polyubiquitin chain (Petroski and Deshaies, 2005) .
In another case, the two steps of chain assembly involve entirely different enzymes: the ubiquitination of PCNA begins with one E3-E2 pair that places the initial ubiquitin on the target, after which a different E3-E2 complex extends a K63-linked ubiquitin chain (Eddins et al., 2006; Hoege et al., 2002) .
The anaphase-promoting complex (APC), or cyclosome, is a large, multisubunit RING-domain E3 required for the completion of mitosis in all eukaryotes (Morgan, 2007; Peters, 2006; Thornton and Toczyski, 2006) . The APC ubiquitinates securin, allowing chromosome segregation, and mitotic cyclins, promoting mitotic exit and the establishment of G1. APC activity is regulated by its association with activator subunits, Cdc20 and Cdh1, which help mediate the interaction between the APC and specific destruction sequences on its substrates. During mitosis, the APC is activated first by association with Cdc20, which targets securin and some cyclins at the metaphase-to-anaphase transition. Cdh1 is activated later in mitosis, resulting in further cyclin destruction and the maintenance of APC activity in G1.
A major unsolved problem in APC biology is the identity of the E2s that collaborate with the APC in vivo. In higher eukaryotes, APC function is thought to depend on at least two E2 proteins whose names in human cells are UbcH5 (also known as Ubc4) and UbcH10 (also named UbcX and E2-C in some species; Aristarkhov et al., 1996; Hershko et al., 1994; King et al., 1995; Kirkpatrick et al., 2006; Mathe et al., 2004; Townsley et al., 1997; Yu et al., 1996) . Homologs of these two proteins are both essential for timely mitotic progression and cyclin destruction in fission yeast (Seino et al., 2003) . A recent analysis suggests that vertebrate UbcH5 and UbcH10 promote monoubiquitination of APC targets as well as the assembly of short polyubiquitin chains that display little lysine specificity (Kirkpatrick et al., 2006) . K48-specific polyubiquitination by purified APC has not been observed, suggesting either that it does not occur in vivo or that it depends on E2s that remain to be identified.
In the budding yeast, Saccharomyces cerevisiae, the relevant E2s are not clear. The yeast genome encodes proteins that are related to both UbcH5 and UbcH10 (Ubc4 and Ubc11, respectively), but cells depleted of both enzymes progress normally through the cell cycle (Townsley and Ruderman, 1998) . Ubc4 has a close homolog in yeast, Ubc5, but cells lacking both Ubc4 and Ubc5 are viable, although their growth is impaired (Seufert and Jentsch, 1990) . The same is true of cells depleted of both Ubc5 and Ubc11. Thus, there is no single or multiple E2 defect known to result in a complete loss of APC function, suggesting that we have not yet found all the E2s that collaborate with the yeast APC.
Budding yeast Ubc4 is a well-established APC-dependent E2 that has been used in all previous studies of yeast APC enzymology (Carroll and Morgan, 2005; Passmore et al., 2005) . Deletion of UBC4 is lethal in strains with diminished APC activity (Irniger et al., 1995) . However, Ubc4-dependent reactions with the APC or other E3s do not result in efficient formation of polyubiquitin (Carroll and Morgan, 2002; Wu et al., 2003) , indicating that other E2s may be required to promote chain formation by the APC.
To clarify the mechanisms by which the APC modifies its targets, we identified and characterized the E2s that work with the budding yeast APC. Two E2s were found to be critical: Ubc4 and Ubc1. A detailed comparison of their activities revealed that they act in sequence to promote the two steps in polyubiquitin chain assembly: Ubc4 monoubiquitinates APC targets at multiple lysines, providing a substrate upon which Ubc1 assembles K48-linked polyubiquitin chains.
RESULTS

Identification of APC-Dependent E2s
The yeast genome encodes 13 ubiquitin-conjugating enzyme family members (Ubc1-Ubc13). We purified each protein and tested its activity with the APC in vitro. E2s were purified from a library of yeast strains carrying TAP-tagged proteins under the control of their endogenous promoters (Ghaemmaghami et al., 2003) . Seven of the thirteen E2 proteins were readily prepared from extracts of proliferating cells ( Figure 1A ). Of the remaining six E2s, Ubc6 and Ubc7 were present in denaturing lysates but could not be recovered from native lysates, presumably because these two enzymes participate in the ERAD pathway and are connected to the ER membrane (Biederer et al., 1997; Sommer and Jentsch, 1993) . The remaining four enzymes (Ubc5, Ubc10, Ubc11, and Ubc12) were not detected in denatured whole lysates and thus appear to be poorly expressed in cycling cells.
The seven Ubc enzymes present in native lysates from log-phase cells were purified and added to reactions containing E1, ATP, ubiquitin, APC, Cdh1, and radiolabeled securin to monitor ubiquitination. As expected, TAP-tagged Ubc4 purified from yeast promoted APC activity toward securin. Of the remaining six E2s tested, only Ubc1 also supported robust APC-dependent securin ubiquitination ( Figure 1A) .
We also tested the E2s that we could not detect in proliferating cells. Ubc11 and Ubc12 were produced by overexpression in yeast. Ubc12, as expected for a Nedd1-dependent enzyme, was not able to conjugate ubiquitin (data not shown; Liakopoulos et al., 1998 ). Ubc11 promoted a low level of APC-dependent ubiquitination of securin and sea urchin cyclin B ( Figure S1A ; data not shown). We also tested Ubc5 produced in bacteria. As expected from its high degree of homology to Ubc4, Ubc5 also promoted APC-dependent ubiquitination of both substrates ( Figure S1B ; data not shown). Like Ubc4, both Ubc11 and Ubc5 catalyzed the addition of relatively few ubiquitins per substrate. Although Ubc11 and Ubc5 are able to support some APC activity in vitro, their undetectable expression in proliferating cells, their increased expression in meiosis, and the minimal effects of their gene deletions all suggested to us that they are not critical APC partners in mitosis (Chu et al., 1998; Seufert and Jentsch, 1990; Townsley and Ruderman, 1998) . We therefore focused our efforts on Ubc1 and Ubc4.
Ubc1 and Ubc4 Generate Different Reaction Products
We purified 6-histidine-tagged Ubc1 and Ubc4 from E. coli by metal affinity chromatography. Both enzymes accepted ubiquitin from E1 (see Figure 2A below) and supported APC-dependent ubiquitination of securin in vitro in a purified system ( Figure 1B ). Ubc4 was able to completely deplete the initial substrate under these conditions, while Ubc1 used only a small fraction of the initial substrate. Ubc4 therefore displays greater activity toward unmodified substrate. However, Ubc1 promoted the formation of higher molecular weight products than Ubc4, indicating that more ubiquitins were added per substrate molecule. Ubc1 also generated higher molecular weight products in reactions with other substrates ( Figure 1C) .
The activating subunit in these experiments was Cdh1, which is more readily prepared in active form than Cdc20. Similar results were obtained using Cdc20 that was produced by translation in vitro ( Figure S2 ), indicating that the distinct behaviors of Ubc1 and Ubc4 are seen with both activating subunits.
Ubc1 Promotes the Formation of K48-Linked Polyubiquitin Chains
To test whether the highly ubiquitinated products generated by Ubc1 were polyubiquitin chains, we carried out reactions with methylated ubiquitin in which all seven lysines in ubiquitin are chemically blocked and thus not available for chain formation. Incubation of methyl-ubiquitin with Ubc4 or Ubc1 resulted in the formation of E2-Ub conjugates that could be detected on a nonreducing polyacrylamide gel, confirming that both E2s are able to accept the different ubiquitin species equivalently ( Figure 2A ).
We first used the N terminus of sea urchin cyclin B as a substrate. With Ubc4 as the E2 in the reaction, we mainly observed mono-, di-, and triubiquitinated species in reactions with wild-type ubiquitin ( Figure 2B ). As seen in our previous work, when methyl-ubiquitin was used, triubiquitinated species were slightly reduced but the mono-and diubiquitinated species were unaffected (Carroll and Morgan, 2002) . Thus, Ubc4 primarily promotes monoubiquitination of multiple lysines in cyclin B but is not effective in promoting chain formation. The slight reduction in the triubiquitinated species as well as the loss of the heterogeneous bands above the triubiquitinated species suggest that limited chain formation did occur.
We carried out the same analysis with Ubc1. Reaction products with wild-type ubiquitin included at least eight ubiquitinated species, present in roughly equal amounts. Only a single band was observed in reactions with methyl-ubiquitin, indicating that the higher species seen with unmodified ubiquitin are polyubiquitinated. Thus, Ubc1 catalyzes polyubiquitin chain formation.
The same result was obtained using yeast securin as substrate, although in the case of Ubc4 with ubiquitin or methyl-ubiquitin the pattern was different, indicating that some polyubiquitin chains were present ( Figure 2C ). We next carried out reactions with three different ubiquitin point mutants in which single lysines were mutated (K29R, K48R, and K63R). All mutants were conjugated efficiently to both Ubc1 and Ubc4 ( Figure 2A ). In Ubc4-dependent reactions with these point mutants, the pattern of ubiquitination was the same as that with wild-type ubiquitin, indicating that the few chain linkages in these reactions were not occurring at specific lysines in ubiquitin (Figures 2B and 2C) . In reactions with Ubc1, however, the K48R mutant specifically lacked polyubiquitinated species, indicating that Ubc1-dependent chains are linked at lysine 48.
Ubc1 Catalyzes Processive Modification of Preubiquitinated Substrate
Our studies suggested that Ubc1 catalyzes the formation of polyubiquitin chains, but turnover of unmodified substrate into ubiquitinated species appeared slower than that with Ubc4 ( Figure 1B ). We characterized these differences further by analyzing substrate ubiquitination at various concentrations of Ubc4 and Ubc1 ( Figure 3A ). Half-maximal stimulation of cyclin ubiquitination occurred at roughly equal concentrations of the two E2s (1.19 ± 0.12 mM Ubc1 and 2.80 ± 0.32 mM Ubc4; Figure 3B ). Most importantly, at saturating E2 concentrations the rate of cyclin turnover (that is, depletion of unmodified substrate) was about 10-fold higher with Ubc4 than with Ubc1, consistent with the earlier indication that Ubc4 was able to convert more original substrate into ubiquitinated species ( Figure 1B) .
To assess processivity in these reactions, we also calculated the amounts of ubiquitin added per molecule of modified cyclin B ( Figure 3C ; Carroll and Morgan, 2005) . As anticipated, Ubc1 was 2-to 3-fold more processive than Ubc4 by this measure.
A likely explanation for these results is that the depletion of cyclin in these assays is limited by the attachment of the first ubiquitin; that is, the rate of substrate depletion is determined by the rate at which the first ubiquitin is added to an unmodified substrate. Given its preference for K48 of ubiquitin, Ubc1 might have low activity in this first step but have much higher activity in subsequent steps with substrates that are already ubiquitinated. To test this possibility, we isolated preubiquitinated species from the products of a Ubc4-dependent reaction, which generally produces equal amounts of mono-, di-, and triubiquitinated species (for examples, see Figures 2B and 3A) . We isolated these species by separating reaction products on a polyacrylamide gel and then extracting radiolabeled proteins from excised gel fragments. Different species were then used in reactions with either Ubc1 or Ubc4. As we showed previously (Carroll and Morgan, 2002) , Ubc4 did not display a preference for preubiquitinated substrates ( Figure 4A ). In contrast, Ubc1 had significantly higher activity with substrates that were already ubiquitinated, using monoubiquitinated cyclin B at least 10-fold more rapidly than unmodified cyclin B ( Figures  4B and 4C ).
When we compared the rate of ubiquitin incorporation as opposed to cyclin turnover, we found that Ubc1 was twice as fast as Ubc4 when monoubiquitinated cyclin was the substrate ( Figure 4D ). This observation further suggests that Ubc1 prefers to make chains and that the slow, rate-limiting step in Ubc1 reactions with unmodified substrate is the addition of the first ubiquitin to a lysine on the substrate. Once the substrate carries a ubiquitin, however, Ubc1 catalyzes more rapid ubiquitin transfer (through a K48 linkage) than Ubc4 (which modifies nonspecific lysines in the substrate or ubiquitin). These results suggest that Ubc4 and Ubc1 act synergistically in the ubiquitination of APC targets. We tested this hypothesis by measuring APC-dependent ubiquitination of cyclin B in the presence of both E2 enzymes under limiting APC conditions ( Figure 4E ). When we measured the appearance of polyubiquitinated cyclin carrying more than three ubiquitins, we observed that chain formation was far more rapid in the presence of both E2s than it was in the presence of either E2 alone ( Figure 4F ). This high polyubiquitination activity was specific to the combination of Ubc4 and Ubc1, as it was not seen in reactions with twice the amount of Ubc4 alone or Ubc1 alone (data not shown). These data suggest that Ubc4 and Ubc1 can act sequentially, with Ubc4 products being extended by Ubc1 as seen in Figure 4B .
Measurements of the total turnover of unmodified cyclin B revealed that Ubc4 alone was better at converting cyclin B to ubiquitinated species than either Ubc1 alone or Ubc1 and Ubc4 together ( Figure 4G ). Ubc1 therefore inhibits the ability of Ubc4 to modify the substrate under these conditions of limiting APC levels, as might be expected if the two E2s compete for the same or overlapping binding sites on the APC.
The UBA Domain of Ubc1 Contributes to the Processivity of Chain Assembly Ubc1 is unique among the yeast E2s in that it contains not only a ubiquitin-conjugating (UBC) domain but also a ubiquitin-associated (UBA) domain at its C terminus (Merkley and Shaw, 2004) . Previous studies have shown that a deletion of the UBA domain on Ubc1 alters the pattern of its autoubiquitination, but its function has not been assessed in an E3-dependent reaction (Hodgins et al., 1996) . UBA domains bind ubiquitin (Hicke et al., 2005) , and thus a reasonable hypothesis is that the UBA domain of Ubc1 aids in its ability to form polyubiquitin chains. We tested this possibility by creating a version of Ubc1 that lacks this domain, Ubc1-DUBA, and produced it in bacteria with a C-terminal 6-histidine tag. This truncated protein was as effective as Ubc1 in the conjugation of ubiquitin and ubiquitin mutants (data not shown), indicating that the core ubiquitin-conjugating activity of Ubc1 does not depend on the UBA domain.
As seen in Figure 5A , removal of the UBA domain resulted in a significant decrease in the number of ubiquitins incorporated into an APC substrate, although the number of ubiquitins was still greater than that seen with Ubc4 (compare Figures 2B and 5A ). The distribution of products was altered: shorter products were more common than longer products in the case of Ubc1-DUBA, whereas full-length Ubc1 tended to generate equal amounts of the different species. The UBA domain is therefore required for the full processivity of Ubc1.
Like full-length Ubc1, the truncated mutant promotes the formation of polyubiquitin chains, as indicated by the loss of activity in reactions with methyl-ubiquitin (Figure 5A) . We also tested the linkage specificity and again observed a complete preference for K48-linked chains in the absence of the UBA domain. We conclude that the UBA domain contributes to polyubiquitin chain assembly but that the core UBC domain determines specificity for the lysine on ubiquitin.
We also compared the rates and products of the ubiquitination reactions at different concentrations of wild-type and truncated Ubc1 (Figures 5B and 5C ). Halfmaximal stimulation of cyclin turnover with Ubc1-DUBA occurred at 10-fold higher concentrations than those for Ubc1 ( Figure 5D ), suggesting that Ubc1-DUBA has a lower affinity for the APC or substrate. Interestingly, maximal activity varied in the opposite manner, with Ubc1-DUBA having a 10-fold higher V max than Ubc1, resulting in identical k cat /K 1/2 values. In a comparison of processivities (A) Recombinant Ubc4 (4.8 nM to 48 mM in equal steps) or Ubc1 (6.6 nM to 66 mM in equal steps) was added to E1, ATP, and ubiquitin and incubated for 15 min at room temperature. The E1/E2 mix was added to the APC Cdh1 mix containing 125 I-cyclin B and allowed to react until no more than 2% of the initial substrate was used. Reactions were stopped by addition of SDS sample buffer, analyzed by SDS-PAGE, and visualized with a PhosphorImager.
(B) The rate at which cyclin was converted to any ubiquitinated species was determined by quantifying the total amount of ubiquitinated substrate. For Ubc4 reactions, the mono-, di-, and triubiquitinated species were quantified, while for Ubc1, the eight major ubiquitinated species were quantified. Data were fit to a rectangular hyperbola using the ligand-binding module provided with Sigma Plot. This data is representative of three independent experiments. The inset provides a scaled version of the Ubc1 curve. (C) Processivity was determined by calculating the ratio of ubiquitin to cyclin in the products as described (Carroll and Morgan, 2005) . Data were fit to a rectangular hyperbola as in (B).
( Figure 5E ), Ubc1 reached a higher value at a lower E2 concentration than Ubc1-DUBA, with the latter never able to achieve the processivity of Ubc1. We therefore suspect that Ubc1-DUBA has a defect in binding to the APC-substrate complex (resulting in a processivity defect) but is not defective in catalysis or linkage specificity. The high cyclin-depleting activity of Ubc1-DUBA may indicate that the UBA domain reduces activity toward unmodified targets, and in its absence this restriction is relaxed.
Human E2-25K Promotes Modification of Preubiquitinated APC Targets Our studies of yeast Ubc1 raised the possibility that higher eukaryotes might also employ an E2 that is specialized for the second, K48-specific, step in polyubiquitin chain assembly on APC substrates. On the basis of amino acid sequence, the closest human homolog of yeast Ubc1 is E2-25K/Hip2, a well-known E2 that was among the first to be characterized in biochemical detail (Chen and Pickart, 1990; Chen et al., 1991) . Like Ubc1, E2-25K contains a C-terminal UBA domain (Haldeman et al., 1997; Merkley and Shaw, 2004) and is known to catalyze the formation of unanchored K48-linked polyubiquitin chains (Chen and Pickart, 1990) . Little is known about its biological function or E3 partners; recent studies suggest that E2-25K, like yeast Ubc1, may serve as an E2 for E3s involved in the ER-associated degradation (ERAD) pathway (Flierman et al., 2006) . Thus, there are clearly many parallels between yeast Ubc1 and human E2-25K, suggesting that E2-25K may contribute to APC function.
We tested the activity of E2-25K with APC Cdh1 immunopurified from extracts of human HeLa cells ( Figure 6A ) or from frog embryonic cells (data not shown). In both cases, E2-25K displayed low but reproducible activity with unmodified substrates, including cyclin ( Figure 6A ) and securin (data not shown). More importantly, we noted that mixing E2-25K with human UbcH10 consistently resulted in greater polyubiquitination of substrates than was achieved with UbcH10 alone (Figure 6A ), suggesting (C and D) Cyclin turnover and ubiquitin incorporation were measured for reactions using cyclin and monoubiquitinated cyclin as starting substrates. Note that in (D) the two Ubc4 curves are superimposed. (E) APC reactions were carried out in the presence of Ubc4 (0.5 mg), Ubc1 (0.5 mg), or a combination of both enzymes at these concentrations. After the indicated times, reactions were stopped by addition of SDS sample buffer, analyzed by SDS-PAGE, and visualized with a PhosphorImager. (F) The amount of ubiquitinated products above the triubiquitinated species was quantified using ImageQuant. (G) All ubiquitinated products were quantified, providing a measure of the total amount of cyclin converted to ubiquitinated species. that E2-25K, like Ubc1, might be specialized for the modification of substrates carrying preattached ubiquitins. We therefore measured E2-25K activity toward cyclin that was already modified with one or two ubiquitins, as in our studies of Ubc1. The activity of E2-25K was stimulated about 3-fold by the presence of one ubiquitin on the substrate, and two ubiquitins resulted in a dramatic 15-fold increase in activity ( Figure 6B, top) . Thus, E2-25K, like Ubc1, displays a clear preference for preubiquitinated targets and is well suited for the second step in polyubiquitin chain formation. Because E2-25K is known to possess E3-independent ubiquitin chain-forming activity (Chen and Pickart, 1990) , we also analyzed its activity in the absence of APC ( Figure 6B, bottom) . A low level of activity was detected, but the addition of APC increased this activity 6-to 8-fold with any of the three substrates. We therefore conclude that E2-25K behaves much like Ubc1 and might therefore serve as an APC-dependent chainextending E2 in human cells.
Ubc1 and Ubc4 Are Required for APC Function
In Vivo A prediction from our studies in vitro is that both Ubc1 and Ubc4 collaborate with the APC in the yeast cell to promote ubiquitination of substrates important for cell-cycle progression. Previous studies have shown that Ubc4 is not required for the efficient degradation of mitotic cyclins (Townsley and Ruderman, 1998) , but the contribution of Ubc1 to APC function has not been assessed. We first characterized the effects of deleting the UBC1 gene and found that Ubc1 is essential in our strain background (W303). We therefore turned to conditional expression of UBC1 by placing the chromosomal copy of UBC1 under the control of the P GAL1 promoter, with a 3xHA tag at the protein's N terminus. This strain was viable on media containing galactose but displayed a severe growth defect when UBC1 expression was repressed on media containing glucose ( Figure 7A ). When we streaked for single cells on dextrose plates, we observed multiple rounds of division, resulting in microcolonies containing filamentous clusters of cells lacking a uniform bud-size phenotype (data not shown). We also constructed a P GAL1 UBC1 strain in which UBC4 was deleted. When plated on repressive glucose media, this double mutant strain was completely inviable ( Figure 7A) .
Loss of APC function is known to result in a metaphase arrest with high levels of securin and mitotic cyclins. Deletion of all APC-dependent E2s should generate a similar phenotype unless those E2s have important collaborations with E3s involved in other processes. To further analyze the cell-cycle defects in the P GAL1 UBC1 and P GAL1 UBC1 ubc4D strains, cells were arrested in G1 with a factor in the presence of galactose. Glucose was added to repress UBC1 transcription, and after two hours cells were released from the a factor arrest into media containing glucose. No Ubc1 was detectable by western blotting of lysates from either strain ( Figure 7B , Ubc1 western). We compared cell-cycle events and APC substrate levels in wild-type, P GAL1 UBC1, ubc4D, and P GAL1 UBC1 ubc4D cells ( Figure 7B ).
Cells lacking UBC1 alone displayed several mitotic defects. Analysis of DNA and spindle morphology revealed a delay in the initiation of spindle elongation and chromosome segregation as well as a delay in spindle disassembly. The final step in cell separation was highly defective, as indicated by the observation that the two daughter cells remained connected to the end of the experiment. This connection could be severed by digesting the cell wall with zymolyase. Analysis of APC substrate levels was consistent with these phenotypes: securin accumulated to abnormally high levels and was destroyed only after a delay, while the destruction of Clb2 and Cdc20 was completely blocked. Ubc1 is therefore required for the normal destruction of APC targets and is particularly critical for that of Clb2, resulting in various partial defects in late mitotic events. (B and C) Recombinant Ubc1 (6.6 nM to 66 mM in equal steps) or Ubc1-DUBA (6.6 nM to 66 mM in equal steps) was used in APC Cdh1 ubiquitination assays as in Figure 3A .
(D and E) Total cyclin turnover and reaction processivity were measured as described in Figures 3B and 3C .
Cells lacking UBC4 also displayed defects in late mitotic events, including delays in anaphase onset and spindle disassembly that were accompanied by partial defects in the destruction of securin and Clb2 ( Figure 7B ). Double mutants lacking both UBC1 and UBC4 displayed more severe defects than either single mutant. The metaphase-toanaphase transition was completely blocked, resulting in a complete arrest with a single DNA mass over a short preanaphase spindle at the bud neck. All APC substrates tested were stabilized in this arrest. Ubc1 and Ubc4 are therefore required for APC activity during mitosis.
We also analyzed cell-cycle progression in P GAL1 UBC1 ubc5D and P GAL1 UBC1 ubc11D cells. When these cells were released from a G1 arrest in the presence of glucose to repress UBC1 expression, the mitotic defects in double mutants were the same as those in the absence of UBC1 alone (data not shown). Thus, Ubc5 and Ubc11 do not make significant contributions to APC function in the absence of Ubc1.
Our observation that cells lacking UBC1 are particularly defective in Clb2 destruction and late mitotic events suggested that the inviability of this strain is due primarily to defects in Cdk1 inactivation in late mitosis. Consistent with this possibility, we found that P GAL1 UBC1 cells are viable on glucose plates when they are engineered to express high levels of the Cdk inhibitor Sic1 (Figure S3 ).
DISCUSSION
The biochemical features of Ubc4 and Ubc1 suggest that they operate in sequence to promote the two steps of polyubiquitination: Ubc4 is best suited for the nonspecific monoubiquitination of multiple lysines in the target, yielding an ideal substrate upon which Ubc1 can assemble K48-linked polyubiquitin chains.
The K48 linkage specificity of Ubc1 is not affected by removal of its C-terminal UBA domain, indicating that specificity is determined by the core ubiquitin-conjugating domain. The K48-linkage specificity of Cdc34 (Ubc3), the primary E2 for the ubiquitin-protein ligase SCF, depends on an acidic loop near its catalytic cysteine (Petroski and Deshaies, 2005) . This loop is not present in Ubc1, and so the sequence determinants of Ubc1 specificity remain unclear.
Removal of the UBA domain results in shorter reaction products than those seen with wild-type Ubc1. In addition, the concentration of Ubc1-DUBA required for halfmaximal activity is far higher than that for the wild-type protein. A likely explanation for these results is that the UBA domain interacts with ubiquitin on a preubiquitinated target, thereby enhancing the affinity of Ubc1 for the APCsubstrate complex. It remains unclear if Ubc1 promotes modification of K48 in the UBA-bound ubiquitin itself or in an adjacent ubiquitin. Even if the substrate carries only a single ubiquitin, the interaction of that ubiquitin with Ubc1 might stimulate monoubiquitination of nearby lysines in the target protein, resulting in additional substrates upon which chains can be built.
Ubc1 and Ubc4 Collaborate In Vivo to Promote APC Target Destruction
Our studies of ubc1D and ubc4D cells indicate that the sequential actions of the two E2s are critical for the normal timing of mitotic events: the loss of either E2 results in the partial stabilization of APC substrates and delays in the onset and completion of anaphase and other events. The loss of both Ubc1 and Ubc4 results in a complete arrest in metaphase, clearly arguing that these two proteins alone serve as the E2 partners for the APC in the mitotically proliferating yeast cell.
Repression of UBC1 expression results in a late mitotic arrest that appears to be due primarily to a defect in Clb2 destruction and thus Cdk1 inactivation, as it is suppressed by overproduction of the Cdk1 inhibitor Sic1. This phenotype appears to be a less severe form of the phenotype Figure 4 . E2-25K (4 mg) was incubated with E1, ATP, and ubiquitin and added to human APC supplemented with Cdh1 and the indicated substrate (top). Control reactions (bottom) were mixed with buffer lacking APC Cdh1 . After the indicated times at 37 C, reactions were stopped by addition of SDS sample buffer, analyzed by SDS-PAGE, and visualized with a PhosphorImager. Note that a deubiquitinating activity copurifies with the APC in these experiments, resulting in some loss of ubiquitin during the reaction.
that results from expression of a nondegradable Clb2 mutant, which is also rescued by Sic1 overproduction (Wä sch and Cross, 2002) . Given that Clb2 destruction depends partly on Cdc20 and that Cdh1 is not essential for viability, these results argue that the ubc1D phenotype is not simply the result of a defect in Cdh1-specific APC activity. Cells lacking Ubc4 alone display a minor mitotic delay but eventually degrade all major APC targets; thus, the poor monoubiquitination activity of Ubc1 may be sufficient in vivo, or other factors in the cell may boost this activity. Cells lacking Ubc1 alone display a more pronounced defect in APC-dependent protein destruction: these cells eventually degrade securin and Clb5 but not Cdc20 and Clb2. When UBC4 is also deleted, destruction of all major APC targets is blocked. Thus, Ubc4 alone appears capable of promoting the destruction of some APC targets despite its poor polyubiquitin chain-forming activity. As suggested recently, an array of short chains produced (B) Asynchronous cultures of the indicated cells (À5 hr time point) were treated with a factor for 3 hr (À2 hr time point), after which glucose was added for 2 hr. Alpha factor was then washed out (zero time point), and at the indicated times cells were analyzed directly for budding index (black squares). Parallel samples were fixed and treated with zymolyase for analysis of DNA masses with DAPI staining and spindle structure with anti-tubulin antibodies, allowing measurement of chromosome segregation (binucleate cells, white circles) and elongated anaphase spindles (black triangles). Additional samples were prepared for western blotting analysis of the indicated proteins. Note that budding index is generally higher than the percentage of binucleate cells because chromosome masses, but not budding, were counted after treatment with zymolyase, which separates cells connected only by the cell wall.
by Ubc4-APC may be sufficient to target some proteins for destruction (Kirkpatrick et al., 2006) . Alternatively, chainextending activities or E4s (Hoppe, 2005) may assist Ubc4-APC in the polyubiquitination of some targets. These mechanisms may explain why securin is eventually destroyed in the absence of Ubc1, but it remains unclear why Clb2 and Cdc20 remain stable. One possibility is that Clb2 and Cdc20 are relatively poor substrates of APC-Ubc4, so that their rate of ubiquitination is insufficient to oppose the rate of deubiquitination in the cell. The timing of substrate destruction in vivo is likely to depend, at least in part, on the processivity of substrate ubiquitination by the APC (Rape et al., 2006) , and the processivity of Clb2 and Cdc20 ubiquitination by APC-Ubc4 may not be sufficient for its destruction in vivo. E2s other than Ubc4 and Ubc1 do not appear to make significant contributions to mitotic APC activity. We did find, however, that Ubc5 and Ubc11 catalyze APC-dependent monoubiquitination in vitro. Interestingly, expression of the genes encoding these two proteins is induced upon entry into meiosis, whereas UBC4 expression is repressed (Chu et al., 1998) . Perhaps one or both of these E2s fulfils the role of Ubc4 in the meiotic program.
Sequential E2 Action May Be a Conserved Mechanism in APC Function
Our work is reminiscent of previous studies in fission yeast, where two E2s have been implicated in cyclin destruction and mitotic progression (Seino et al., 2003) . Depletion of the Ubc4 homolog, UbcP1, leads to the accumulation of low molecular weight cyclin-ubiquitin species in vivo, while depletion of a UbcH10 homolog, UbcP4, results in the accumulation of nonubiquitinated cyclin. These results are consistent with the possibility that the two E2s generate different products, but detailed biochemical studies of these products have not been performed. The vertebrate homologs of these E2s, UbcH5 and UbcH10, are not believed to generate extensive polyubiquitin chains (Kirkpatrick et al., 2006) , and so it remains possible that UbcP1 and UbcP4 are supplemented by a fission yeast Ubc1 homolog or some other chainextending activity.
In vertebrates, UbcH5 and UbcH10 are thought to be the two major E2s that collaborate with the APC. Both were identified biochemically as the major APC-dependent E2 activities in extracts of frog and clam embryos (Aristarkhov et al., 1996; King et al., 1995; Yu et al., 1996) . RNAi-mediated depletion of UbcH10 from human cells, or the homologous protein, Vihar, in Drosophila causes partial mitotic defects accompanied by stabilization of APC targets (Mathe et al., 2004; Rape and Kirschner, 2004) . Apart from these experiments, there has been no systematic analysis in higher eukaryotes of the requirement for different E2s in APC function, and there is no evidence to rule out the possibility that E2s other than UbcH5 and UbcH10 are involved.
Our studies suggest that E2-25K also contributes to APC function in vertebrate cells. E2-25K is the closest human homolog of Ubc1 by sequence, and it shares many other features with yeast Ubc1: it catalyzes K48-linked polyubiquitin formation (Chen and Pickart, 1990) , it contains a UBA domain at its C terminus (Haldeman et al., 1997) , and it has been implicated in the ERAD pathway (Flierman et al., 2006) . We found that E2-25K is an effective catalyst of APC-dependent ubiquitination of substrates carrying preattached ubiquitins. It has little activity with unmodified substrates, perhaps explaining why it was never identified as a major APC-dependent E2 activity in previous biochemical studies. We therefore speculate that sequential E2s operate in human cells as in yeast: UbcH5 and UbcH10 may add the first ubiquitins to APC targets, after which E2-25K extends K48-linked chains on those ubiquitins.
Sequential E2 Action as a General Mechanism in Polyubiquitin Chain Formation
Our work reveals how the APC solves an important general problem in the mechanism of protein polyubiquitination: how a single E3 can efficiently promote both monoubiquitination of nonspecific lysines in a target and highly specific K48 ubiquitination of ubiquitins on that target. The strategy used by the APC to solve this problem-a pair of E2s, each specialized for one of the two steps in chain formation-contrasts with the strategy used by the related E3, SCF, which employs a single E2, Cdc34, to catalyze both steps. What advantage might there be to using two E2s instead of one? One possibility is that two specialized E2s allow more rapid polyubiquitination than a single E2. In the case of Cdc34, for example, the initial monoubiquitination step is slow and limits the overall rate of polyubiquitination; in the case of the APC, this problem is solved by introducing a second E2, Ubc4, that drives rapid nonspecific monoubiquitination of targets. We speculate that it would be difficult to evolve a single E2 that is efficient at both steps in chain formation: the first step requires a flexible active site environment that allows any lysine to attack, while the second step requires a more selective active site that channels lysine 48 of ubiquitin for attack.
The use of sequential E2s may be a general mechanism in polyubiquitin chain assembly by other E3s. There are numerous examples of ubiquitin-dependent degradation processes that appear to depend on multiple E2s. For example, Ubc7, Ubc6, and Ubc1 all contribute to the degradation of proteins in the yeast ERAD pathway (Meusser et al., 2005) , and human ERAD may depend on homologs of Ubc1 and Ubc7 (Flierman et al., 2006) . In these and other cases, different E2s may display distinct biochemical features that together allow more efficient polyubiquitination than is possible with a single E2.
EXPERIMENTAL PROCEDURES
Strains and Plasmids
All yeast strains were derived from W303 except for strains from the TAP library. P GAL1 3xHA-UBC1 was constructed by standard PCR-targeting techniques by direct replacement of the UBC1 promoter with the GAL1 promoter and 3xHA sequence (Longtine et al., 1998) . Construction of Ubc1 and Ubc4 for protein expression was carried out by standard techniques. UBC1 and UBC4 were PCR-amplified lacking the stop codon and were ligated into the pET23d vector to generate a C-terminally 6xHis tagged protein. UBC1 was PCR amplified using an internal 3 0 oligonucleotide to create Ubc1-DUBA (residues 1-150).
Expression and Purification of E2 Proteins
Yeast strains expressing C-terminally TAP-tagged UBC genes were obtained from the library constructed at UCSF (Ghaemmaghami et al., 2003) . One liter cultures were grown to an OD 600 of 1.0, harvested, and lysed by bead-beating into 2.5 volumes of TAP lysis buffer (20 mM HEPES pH 8.0, 150 mM NaCl, 0.1% NP40) supplemented with 50 mM b-glycerophosphate, 50 mM NaF, 1 mM DTT, 1 mM PMSF, and 1 mg/ml each of aprotinin, pepstatin, and leupeptin. Lysate was clarified by ultracentrifugation (1 hr, 100,000 3 g, 4 C) and added to 50 ml of IgG beads pre-equilibrated in TAP lysis buffer. After an overnight incubation at 4 C, beads were washed twice in TAP lysis buffer and once in TEV cleavage buffer (TAP lysis buffer plus 0.5 mM EDTA and 1 mM DTT). Beads were incubated 30 min at room temperature in 50 ml of TEV cleavage buffer and 2 ml of recombinant TEV protease, and cleaved proteins were recovered for ubiquitination assays. For bacterial expression, plasmids containing C-terminally tagged UBC1 and UBC4 were transformed into BL21 cells. A single colony for each gene was incubated overnight in 100 ml LB/Amp media at 37 C, diluted into 1 l of fresh media, and grown at 37 C to an OD 600 of 0.60, after which IPTG was added to 1 mM for 4 hr at 37 C. Cells were harvested by centrifugation, washed in cold water, and frozen in liquid nitrogen. Frozen pellets were melted rapidly and dripped into a mortar containing liquid nitrogen, where they were ground with a pestle to a fine powder. The powder was added to 4 volumes of breakage buffer (50 mM HEPES pH 7.4, 300 mM NaCl, 10% Glycerol plus protease inhibitors lacking DTT or any reducing agent), and the mixture was sonicated five times for 30 s each, alternating with 45 s breaks. Lysates were centrifuged (1 hr, 100,000 3 g, 4 C), and supernatants were subjected to purification by metal affinity chromatography on a 1 ml Pharmacia Hi-Trap column charged with Co +2 .
Fractions containing purified protein were pooled and dialyzed into QAH buffer (50 mM HEPES pH 7.4, 100 mM NaCl, 1 mM MgCl 2 ) plus 10% glycerol and 1 mM b-mercapto-ethanol. The resulting stocks of Ubc1 (5 mg/ml), Ubc4 (2.5 mg/ml), and Ubc1-DUBA (5 mg/ml) were stored at À80 C.
Ubiquitination Assays
Preparation of reaction components (E1, ATP, Ubiquitin, APC, Cdh1) was described previously (Carroll and Morgan, 2005) , except that the final calmodulin-binding step was omitted from the APC preparation. To prepare ubiquitin-E2 conjugates, E1 (0.2 ml of 1 mg/ml), ATP (1.0 ml of 16.7 mM), and ubiquitin (1.5 ml of 10 mg/ml) were incubated with E2 proteins for 15 min at room temperature. In separate tubes, APC (1.5 ml of 10 nM), Cdh1 (0.5 ml of 1.5 mM), and radiolabeled substrate were mixed at room temperature. Reactions were initiated by combining the E1/E2 mix with the APC mix in a final volume of 20 ml, except for dose response assays in Figures 3 and 5 (10 ml final volume). Reaction products were analyzed by SDS-PAGE and visualized with a PhosphorImager. Data were quantified as described using ImageQuant and analyzed using the ligand-binding module of SigmaPlot (Carroll and Morgan, 2005) . The expression, purification, and labeling of the N terminus of sea urchin cyclin B has been described previously (Carroll and Morgan, 2005) . All other substrates were produced by coupled transcription and translation in rabbit reticulocyte extracts. Unless specified, substrates produced by this method were not purified; instead, the TNT mixture was treated with NEM prior to ubiquitination reactions, which we find inactivates chain-extending activities present in the lysate. Purification of preubiquitinated cyclin B species was described previously (Carroll and Morgan, 2002) .
Cell Cycle Analysis
Strains were grown at room temperature and arrested in G1 by the addition of a factor (1 mg/ml) for 3 hr in the presence of 2% raffinose and 2% galactose. Two percent glucose was added to all strains for another 2 hr. Cells were washed free of a factor and placed in fresh media containing 2% glucose, and samples were taken every 15 min. Alpha factor (1 mg/ml) was added back after 90% of the cells had budded. Protein extracts were prepared by bead-beating in urea lysis buffer. 3HA-Ubc1 was detected on western blots with 12CA5 monoclonal antibody (Roche). Securin-13Myc was detected with 9E10 monoclonal antibody. Cdc20 and Clb5 were detected with polyclonal antibodies (Santa Cruz BioTech). Polyclonal anti-Clb2 antibodies were a generous gift of Doug Kellogg (University of California, Santa Cruz). DNA was visualized by DAPI staining, and tubulin was visualized by indirect immunofluorescence with antibody YOL1/34 using spheroplasts. The percentage of budded cells was measured from intact cells fixed in ethanol.
Human APC Analysis
HeLa cells were grown, and lysates were prepared, as previously described (Kraft et al., 2006) . Twenty 15 cm dishes of confluent cells were lysed in 5 ml HeLa lysis buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 20 mM b-glycerophosphate, 5 mM MgCl 2 , 1 mM NaF, 0.2% NP-40, 10% Glycerol) plus protease and phosphatase inhibitors. The lysate was clarified by centrifugation (1 hr, 100,000 3 g, 4 C); final protein concentration was 18 mg/ml. APC was purified by immunoprecipitation as follows. Fifty microliters of rabbit anti-Cdc27 antiserum were incubated with 125 ml protein A magnetic beads (Dynal, Invitrogen) for 30 min at room temperature. After one wash in HeLa lysis buffer, 15 mg of lysate were added to the beads and incubated with rocking for 2 hr at 4 C. Beads were washed once with wash buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 0.1% NP-40, 10% Glycerol), twice with wash buffer plus 600 mM NaCl, and once more with wash buffer. Beads were resuspended in 100 ml of wash buffer and distributed into ten ubiquitination reactions. To prepare ubiquitin-E2 conjugates, mammalian E1 (0.55 mg/ml, Boston Biochem), ATP (2.0 ml of 16.7 mM), and ubiquitin (1.5 ml of 10 mg/ml) were incubated 20 min at room temperature with each E2 protein (purified human E2-25K and UbcH10 were gifts of Vincent Chau and Hongtao Yu, respectively). After confirming by gel electrophoresis that ubiquitin conjugation had occurred, E2-ubiquitin conjugates were mixed with human Cdh1 (1.0 ml, a gift of Hongtao Yu), radiolabeled substrate (2.0 ml), and bead-bound human APC (10 ml). Reactions (23 ml) were incubated 1 hr at 37 C.
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